For laboratory research use only. Not for human or veterinary use.
PS-NAD-2607
Analysis summary

NAD+

Sample as received: NAD+

Reference
PS-NAD-2607
SKU
NAD-500MG
Presentation
Lyophilised powder
Analysis date
21 July 2026

Purity

98.70% HPLC-UV

Basis: Area % — the main peak’s share of the total integrated UV signal.

Identity

Not included in this analysis

Expected mass
663.40 Da
Detected mass
Method
HPLC-UV
Detection
UV 215 nm (±4 nm)

Peak integration

#ComponentRT / minArea %PPI %TailingPlates NRes (USP)
15.7171.2587.165
2NAD+6.28398.7588.91.739560.31

Area % the peak’s share of total integrated UV area. PPI % Peak Purity Index, a per-peak spectral-homogeneity measure. Tailing peak symmetry. Plates N column efficiency. Res USP resolution from the adjacent peak; ≥ 1.5 indicates baseline separation.

Sample as received

Form
Lyophilised powder
Colour
White
Condition
As expected
Peaks resolved
2

Notes

Purity is the main peak's share of the total integrated UV signal; the remainder is minor impurities. Mass-spectrometric identity confirmation was not part of this analysis.

Testing

Analysed by an independent third-party analytical laboratory in the United Kingdom using established HPLC methods. The laboratory’s identity, the certificate it issued and its supporting records are released to verified research institutions on request.

Need the full report?

This is a summary of the analytical results. The complete analytical report — including the identity of the testing laboratory, its instrument records and the raw chromatographic data — is available to verified research institutions and qualified laboratories on request.

Request the full report